Saturday, 20 December 2014
Last updated 17 hours ago
Jan 13 2006 | 8:59pm ET
The Securities and Exchange Commission is considering taking action against hedge fund Perry Capital in relation to the firm's trading shares of pharmaceuticals company Mylan Laboratories Inc.
According to a statement released by Perry Capital on Wednesday, a Wells notice was recently sent to the firm's founder, Richard Perry, who was formerly with Goldman Sachs.
Carl Berg, a portfolio manager at Perry, also received a letter from the SEC, saying that regulators are recommending legal action against the firm. The SEC believes that Perry Capital's trading of Mylan shares may have violated certain provisions of federal securities laws, including Sections 10(b) and 13(d) of the Securities Exchange Act of 1934, Perry said in its statement.
The hedge fund, which has $10 billion is assets under management, claims that is has done nothing wrong and plans to respond to regulators.
Dec 1 2014 | 10:21am ET
As 2014 winds down, Northern Trust Hedge Fund Services executives took some time to share their outlook on trends facing the industry in 2015. Read more…
Jeff Sprecher was simply looking for a platform to trade energies when launching ICE 14 years ago but it has grown to reach the pinnacle of both the listed futures and equities world.